Table 5 Metabolic syndrome and the Framingham risk score and measures of probability (percentage) for the occurrence of CVD.
Quintile | FRS | MS risk score that included age | MS risk score | items | Number of MS components | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CVD(n) | Incidence of CVD (/1,000 person years) | HR(95% CI) | CVD(n) | Incidence of CVD (/1,000 person years) | HR(95% CI) | CVD(n) | Incidence of CVD (/1,000 person years) | HR(95% CI) | CVD(n) | Incidence of CVD (/1,000 person years) | aHR(95% CI) | ||
Q1 | 8 | 3.66 | 1.00 | 5 | 2.29 | 1.00 | 29 | 13.26 | 1.00 | 0 | 17 | 9.75 | 1.00 |
Q2 | 36 | 14.14 | 3.69 (1.71,7.94) | 20 | 7.86 | 3.51 (1.31,9.37) | 32 | 12.57 | 1.05 (0.63,1.74) | 1 | 62 | 17.80 | 1.78 (1.04,3.05) |
Q3 | 48 | 23.31 | 6.36 (3.01,13.46) | 49 | 23.80 | 9.76 (3.88,24.57) | 50 | 24.28 | 2.20 (1.37,3.52) | 2 | 85 | 27.44 | 2.73 (1.61,4.60) |
Q4 | 63 | 29.15 | 8.47 (4.05,17.69) | 91 | 42.10 | 19.62 (7.96,48.36) | 72 | 33.31 | 3.01 (1.92,4.74) | 3 | 60 | 34.00 | 3.47 (2.02,5.98) |
Q5 | 123 | 59.67 | 16.99 (8.30,34.78) | 113 | 54.82 | 25.07 (10.18,61.75) | 95 | 46.09 | 4.17 (2.67,6.50) | ā„4 | 54 | 58.39 | 6.13 (3.54,10.60) |
FRS 10-year risk,% | |||||||||||||
ā¤10 | 218 | 21.85 | 1.00 | 211 | 21.15 | 1.00 | 237 | 23.75 | 1.00 | ā¤1 | 79 | 15.11 | 1.00 |
11ā~ā20 | 54 | 58.21 | 4.48 (3.11,6.45) | 60 | 64.68 | 3.44(2.58,4.59) | 33 | 35.57 | 1.48 (1.02,2.14) | 2 | 85 | 27.44 | 1.77 (1.30,2.42) |
>20 | 6 | 54.98 | 5.25 (2.24,12.31) | 7 | 64.14 | 3.04 (1.43,6.48) | 8 | 73.30 | 2.61 (1.28,5.32) | ā„3 | 114 | 42.38 | 2.79 (2.05,3.79) |
